EML4 and head and neck squamous cell carcinoma: The high sensitivity of OncoPrism-HNSCC is borne out by limit of detection studies where EML4::ALK rearrangements were identified in fusion-positive/fusion-negative RNA mixes down to an estimated level of 58 copies of fusion transcript in the 50 ng RNA input of the assay (Supplemental Table 10).